Accueil
Marchés
Graphique & Idées
Algo
Nouvelles
Store
Courtiers
Télécharger
Calendrier Economique
Signaux de trading
Terminal Web
Tapez
/
pour rechercher : @user, $symbol
Recherche
Se connecter
Créer un compte
Français
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Italiano
Türkçe
HOLX
#555
Hologic Inc
75.360
0
+0.07%
Secteur:
Base:
Devise de Profit:
Range quotidien
Range Annuel
Changement quotidien
+0.07%
Changement Mensuel
+0.23%
Evolution sur 6 mois
+1.77%
Changement Annuel
+1.77%
Clôture Précédente
75.305
0
Open
75.330
0
Bid
Ask
Low
75.310
0
High
75.360
0
Volume
202
Marchés
Actions des Marchés US
Soins de Santé
HOLX
Open full chart
Financials
Overview
Relevé
Statistics
Dividends
Quarterly
Annual
Income statement
Balance sheet
Cash flow
Value
Q3, 24
Q4, 24
Q1, 25
Q2, 25
Q3, 25
Q4, 25
Q1, 26
TTM
Cash from operating activities
405.8 M
367 M
189.3 M
169.4 M
343.3 M
355.1 M
229.9 M
1.1 B
Cash from investing activities
42.6 M
595.7 M
22 M
324.3 M
4.3 M
132.1 M
12.1 M
472.8 M
Cash from financing activities
103.8 M
56.8 M
537 M
201.7 M
40.1 M
-1.6 M
10.7 M
250.9 M
Free cash flow
371.9 M
336.7 M
157.7 M
129.2 M
308.6 M
341.4 M
215.2 M
994.4 M
Hologic Inc
Hologic, Inc. is an American medical technology company primarily focused on women's health; it sells medical devices for diagnostics, surgery, and medical imaging.
Nouvelles
HOLX vs. GEHC: Which Women's Health Stock Should You Pick Now?
L’action Hologic atteint un sommet de 52 semaines à 75,37 USD
Hologic stock hits 52-week high at 75.37 USD
How to Play Hologic Stock Post Q1 Earnings and Progress on Buyout?
Is Most-Watched Stock Hologic, Inc. (HOLX) Worth Betting on Now?
Soft Start For $10B-Plus M&A Deals In 2026
Hologic, Inc. (HOLX) Shareholder/Analyst Call - Slideshow (NASDAQ:HOLX) 2026-02-06
Le test Aptima HPV de Hologic reçoit l’approbation de la FDA pour le dépistage primaire
Hologic’s Aptima HPV assay receives FDA approval for primary screening
Hologic (HOLX) International Revenue Performance Explored
Hologic, Inc. (HOLX) is Attracting Investor Attention: Here is What You Should Know
HOLX Stock Slips on Q1 Earnings and Revenue Miss, Margins Crash